Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy.
Cingolani A, Tavelli A, Maggiolo F, Perziano A, Saracino A, Vichi F, Cernuschi M, Guaraldi G, Quiros-Roldan E, Castagna A, Antinori A, d'Arminio Monforte A, On Behalf Of Icona Foundation Study Group. Cingolani A, et al. Among authors: vichi f. J Clin Med. 2022 Jan 17;11(2):471. doi: 10.3390/jcm11020471. J Clin Med. 2022. PMID: 35054165 Free PMC article.
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort<sup/>
d'Arminio Monforte A, Lorenzini P, Cozzi-Lepri A, Mussini C, Castagna A, Baldelli F, Puoti M, Vichi F, Maddaloni A, Lo Caputo S, Gianotti N, Antinori A; the Icona Foundation Study Group. d'Arminio Monforte A, et al. Among authors: vichi f. HIV Clin Trials. 2018 Apr;19(2):52-60. doi: 10.1080/15284336.2018.1440691. Epub 2018 Mar 1. HIV Clin Trials. 2018. PMID: 29493419
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort.
Mondi A, Cozzi-Lepri A, Tavelli A, Rusconi S, Vichi F, Ceccherini-Silberstein F, Calcagno A, De Luca A, Maggiolo F, Marchetti G, Antinori A, d'Arminio Monforte A; Icona Foundation Study Group. Mondi A, et al. Among authors: vichi f. J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227. J Int AIDS Soc. 2019. PMID: 30663278 Free PMC article.
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.
Taramasso L, Lorenzini P, Di Biagio A, Lichtner M, Marchetti G, Rossotti R, Lapadula G, Cozzi-Lepri A, Vichi F, Antinori A, Bonora S, d'Arminio Monforte A; ICONA Foundation Study Group. Taramasso L, et al. Among authors: vichi f. J Antimicrob Chemother. 2019 Nov 1;74(11):3295-3304. doi: 10.1093/jac/dkz353. J Antimicrob Chemother. 2019. PMID: 31504633
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry.
Galli L, Parisi MR, Poli A, Menozzi M, Fiscon M, Garlassi E, Francisci D, Di Biagio A, Sterrantino G, Fornabaio C, Degli Antoni A, Angarano G, Fusco FM, D'Arminio Monforte A, Corbelli GM, Santoro MM, Zazzi M, Castagna A; PRESTIGIO Study Group. Galli L, et al. Open Forum Infect Dis. 2020 Sep 26;7(11):ofaa456. doi: 10.1093/ofid/ofaa456. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33241063 Free PMC article.
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database.
Lombardi F, Giacomelli A, Armenia D, Lai A, Dusina A, Bezenchek A, Timelli L, Saladini F, Vichi F, Corsi P, Colao G, Bruzzone B, Gagliardini R, Callegaro A, Castagna A, Santoro MM; ARCA Study Group. Lombardi F, et al. Among authors: vichi f. Int J Antimicrob Agents. 2021 Feb;57(2):106252. doi: 10.1016/j.ijantimicag.2020.106252. Epub 2020 Nov 28. Int J Antimicrob Agents. 2021. PMID: 33259914 Free article.
General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV.
Bruno SR, Poliseno M, Vichi F, Esperti S, Di Biagio A, Berruti M, Ferrara S, Pisani L, Saracino A, Santantonio TA, Lo Caputo S. Bruno SR, et al. Among authors: vichi f. PLoS One. 2021 Jul 9;16(7):e0254404. doi: 10.1371/journal.pone.0254404. eCollection 2021. PLoS One. 2021. PMID: 34242341 Free PMC article.
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade.
Taramasso L, Bonfanti P, Ricci E, Maggi P, Orofino G, Squillace N, Menzaghi B, Madeddu G, Molteni C, Vichi F, Riguccini E, Saracino A, Santoro C, Guastavigna M, Francisci D, Di Biagio A, De Socio GV; CISAI study group. Taramasso L, et al. Among authors: vichi f. HIV Med. 2022 Jan;23(1):70-79. doi: 10.1111/hiv.13165. Epub 2021 Sep 2. HIV Med. 2022. PMID: 34473897 Free article.
206 results